Skip to main
ALHC
ALHC logo

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 40%
Hold 30%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc is strategically positioned to leverage the anticipated stronger 2026 Medicare Advantage (MA) rate update, particularly as competing managed care organizations (MCOs) reduce benefits. The company's integrated Medicare Advantage and value-based care (MA-VBC) model is expected to facilitate long-term market share growth and above-average financial performance. Additionally, gross profit per member per month (PMPM) for initial cohorts is projected to rise significantly, suggesting a favorable trajectory for profitability as they advance through their membership lifecycle.

Bears say

Alignment Healthcare Inc. faces a negative outlook as it grapples with challenges related to its value-based care (VBC) model, which can be hindered by data friction among different payors and variability in outcomes from employed or affiliated primary care providers (PCPs). Despite achieving a lower average daily cost (ADK) during a period of increased healthcare utilization, the sustainability of such performance remains uncertain, raising concerns about long-term operational reliability. Additionally, while the company operates with a valuation multiple above the long-term range of peer Managed Care Organizations (MCOs), this approach may not adequately reflect the underlying risks and complexities of its healthcare delivery model.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 40% recommend Buy, 30% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.